News - Abraxane, gemcitabine Hcl

Filter

Current filters:

Abraxanegemcitabine Hcl

Popular Filters

Celgene's Abraxane plus gemcitabine extends survival in pancreatic cancer patients

23-01-2013

US biotech firm Celgene Corp (Nasdaq: CELG) says that its Phase III clinical trial of Abraxane (nab-paclitaxel)…

AbraxaneBiotechnologyCelgenegemcitabine HclOncologyResearch

Back to top